Clinical Investigation of the Medical Device "Alexa Volume" for Correction of Midface Volume Loss

Inclusion Criteria: * Twenty-five (25) years of age or older at time of consent. * Desire and willingness for correction or enhancement of his/her mid-face area. * Subjects presenting with loss of volume and contour of the midface area 2 or more score according to MMVS bilaterally. * Nasolabial folds severity grade 2 or more according to WSRS bilaterally. * Treatment-naive subjects for fillers in the areas to be treated in the last 12 months, otherwise as decided by the Investigator. * Subjects with signed informed consent and photo consent. * Medical history and physical examination which, based on the Investigator's opinion, do not prevent the subject from taking part in the investigation and use the investigational medical device (IMD). * Subjects not pregnant, non-breastfeeding. * Subject must be willing to complete the entire course of the investigation. Exclusion Criteria: * Pregnant, planning pregnancy during the investigation or breastfeeding women. * Subjects with known hypersensitivity to any compound of the IMD. * Subjects with history of any other adverse effect, which could prevent the subject from participating in the investigation according to the Investigator's opinion. * Any prior surgery, any prior cosmetic procedures or side effects from previous procedures in the injected area, including permanent fillers, that may interfere with the results. * Subjects with presence of autoimmune disease or other chronic disease that in the opinion of the Investigator may interfere with the outcome of the investigation. * Subjects with active inflammation or infection in the areas of Alexa administration. * Subjects with tattoo and/or scar in the area of Alexa Volume administration that in the Investigator's opinion would interfere with investigation assessments. * Subjects who tend to develop hypertrophic scarring. * Subjects with impaired hemostatic function, which could prevent the subject from participating in the investigation according to the Investigator's opinion. * Subjects with fibrosis, birthmark, or residual material in the area of intended use of Alexa Volume. * Subjects participating in other clinical investigations within 30 days prior to the Visit 1.